XML 36 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share
3 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share . Earnings Per Share
Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period.
Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS.
Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and non-vested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS.
The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts):
 Fiscal Quarter Ended
 December 31,
2021
December 25,
2020
Numerator:
Net income attributable to Dolby Laboratories, Inc.$80,014 $135,198 
Denominator:
Weighted-average shares outstanding—basic101,230 100,716 
Potential common shares from options to purchase common stock1,348 1,767 
Potential common shares from restricted stock units1,201 1,309 
Potential common shares from employee stock purchase plan22 84 
Weighted-average shares outstanding—diluted103,801 103,876 
Net income per share attributable to Dolby Laboratories, Inc.:
Basic$0.79 $1.34 
Diluted$0.77 $1.30 
Antidilutive awards excluded from calculation:
Stock options413 39 
Restricted stock units203 162 
Employee stock purchase plan15